181 related articles for article (PubMed ID: 32172474)
1. Lack of Mutations in POT1 Gene in Selected Families with Familial Non-Medullary Thyroid Cancer.
Orois A; Badenas C; Reverter JL; López V; Potrony M; Mora M; Halperin I; Oriola J
Horm Cancer; 2020 Apr; 11(2):111-116. PubMed ID: 32172474
[TBL] [Abstract][Full Text] [Related]
2. A Truncating Germline Mutation of
He H; Li W; Comiskey DF; Liyanarachchi S; Nieminen TT; Wang Y; DeLap KE; Brock P; de la Chapelle A
Thyroid; 2020 Feb; 30(2):204-213. PubMed ID: 31928178
[No Abstract] [Full Text] [Related]
3. POT1 germline mutations but not TERT promoter mutations are implicated in melanoma susceptibility in a large cohort of Spanish melanoma families.
Potrony M; Puig-Butille JA; Ribera-Sola M; Iyer V; Robles-Espinoza CD; Aguilera P; Carrera C; Malvehy J; Badenas C; Landi MT; Adams DJ; Puig S
Br J Dermatol; 2019 Jul; 181(1):105-113. PubMed ID: 30451293
[TBL] [Abstract][Full Text] [Related]
4. A new POT1 germline mutation-expanding the spectrum of POT1-associated cancers.
Wilson TL; Hattangady N; Lerario AM; Williams C; Koeppe E; Quinonez S; Osborne J; Cha KB; Else T
Fam Cancer; 2017 Oct; 16(4):561-566. PubMed ID: 28389767
[TBL] [Abstract][Full Text] [Related]
5. Clinical and Genetic Features of a Large Monocentric Series of Familial Non-Medullary Thyroid Cancers.
Cirello V; Colombo C; Karapanou O; Pogliaghi G; Persani L; Fugazzola L
Front Endocrinol (Lausanne); 2020; 11():589340. PubMed ID: 33488516
[TBL] [Abstract][Full Text] [Related]
6. A Germline Mutation in the
Srivastava A; Miao B; Skopelitou D; Kumar V; Kumar A; Paramasivam N; Bonora E; Hemminki K; Försti A; Bandapalli OR
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32492864
[TBL] [Abstract][Full Text] [Related]
7.
Shen E; Xiu J; Lopez GY; Bentley R; Jalali A; Heimberger AB; Bainbridge MN; Bondy ML; Walsh KM
J Med Genet; 2020 Oct; 57(10):664-670. PubMed ID: 31937561
[TBL] [Abstract][Full Text] [Related]
8. Identification of susceptibility gene mutations associated with the pathogenesis of familial nonmedullary thyroid cancer.
Zhu J; Wu K; Lin Z; Bai S; Wu J; Li P; Xue H; Du J; Shen B; Wang H; Liu Y
Mol Genet Genomic Med; 2019 Dec; 7(12):e1015. PubMed ID: 31642198
[TBL] [Abstract][Full Text] [Related]
9. Telomere length is shorter in affected members of families with familial nonmedullary thyroid cancer.
He M; Bian B; Gesuwan K; Gulati N; Zhang L; Nilubol N; Kebebew E
Thyroid; 2013 Mar; 23(3):301-7. PubMed ID: 23009101
[TBL] [Abstract][Full Text] [Related]
10. Association of the POT1 Germline Missense Variant p.I78T With Familial Melanoma.
Wong K; Robles-Espinoza CD; Rodriguez D; Rudat SS; Puig S; Potrony M; Wong CC; Hewinson J; Aguilera P; Puig-Butille JA; Bressac-de Paillerets B; Zattara H; van der Weyden L; Fletcher CDM; Brenn T; Arends MJ; Quesada V; Newton-Bishop JA; Lopez-Otin C; Bishop DT; Harms PW; Johnson TM; Durham AB; Lombard DB; Adams DJ
JAMA Dermatol; 2019 May; 155(5):604-609. PubMed ID: 30586141
[TBL] [Abstract][Full Text] [Related]
11. Whole exome and target sequencing identifies MAP2K5 as novel susceptibility gene for familial non-medullary thyroid carcinoma.
Ye F; Gao H; Xiao L; Zuo Z; Liu Y; Zhao Q; Chen H; Feng W; Fu B; Sun L; Jiang X; He D; Jiang H; Yang M; Li L; Chen F; Liu X; Li S; Li Z; Jiang Y; Cheng L; Bu H
Int J Cancer; 2019 Mar; 144(6):1321-1330. PubMed ID: 30132833
[TBL] [Abstract][Full Text] [Related]
12. Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanoma.
Aoude LG; Pritchard AL; Robles-Espinoza CD; Wadt K; Harland M; Choi J; Gartside M; Quesada V; Johansson P; Palmer JM; Ramsay AJ; Zhang X; Jones K; Symmons J; Holland EA; Schmid H; Bonazzi V; Woods S; Dutton-Regester K; Stark MS; Snowden H; van Doorn R; Montgomery GW; Martin NG; Keane TM; López-Otín C; Gerdes AM; Olsson H; Ingvar C; Borg A; Gruis NA; Trent JM; Jönsson G; Bishop DT; Mann GJ; Newton-Bishop JA; Brown KM; Adams DJ; Hayward NK
J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25505254
[TBL] [Abstract][Full Text] [Related]
13. [Next generation sequencing technology for susceptible gene screening in familial non-medullary thyroid carcinoma].
Dong L; Yu Y; Yu JP; Hao WJ; Zheng XQ; Cheng YN; Han L; Zhao JZ; Gao M
Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):24-28. PubMed ID: 28104029
[No Abstract] [Full Text] [Related]
14. Identification of a Cancer-Predisposing Germline
Jajosky AN; Mitchell AL; Akgul M; Shetty S; Yoest JM; Gerson SL; Sadri N; Oduro KA
Genes (Basel); 2022 Mar; 13(4):. PubMed ID: 35456397
[TBL] [Abstract][Full Text] [Related]
15.
Orois A; Gara SK; Mora M; Halperin I; Martínez S; Alfayate R; Kebebew E; Oriola J
Genes (Basel); 2019 Nov; 10(11):. PubMed ID: 31703244
[TBL] [Abstract][Full Text] [Related]
16. Germline mutations in shelterin complex genes are associated with familial glioma.
Bainbridge MN; Armstrong GN; Gramatges MM; Bertuch AA; Jhangiani SN; Doddapaneni H; Lewis L; Tombrello J; Tsavachidis S; Liu Y; Jalali A; Plon SE; Lau CC; Parsons DW; Claus EB; Barnholtz-Sloan J; Il'yasova D; Schildkraut J; Ali-Osman F; Sadetzki S; Johansen C; Houlston RS; Jenkins RB; Lachance D; Olson SH; Bernstein JL; Merrell RT; Wrensch MR; Walsh KM; Davis FG; Lai R; Shete S; Aldape K; Amos CI; Thompson PA; Muzny DM; Gibbs RA; Melin BS; Bondy ML;
J Natl Cancer Inst; 2015 Jan; 107(1):384. PubMed ID: 25482530
[TBL] [Abstract][Full Text] [Related]
17. CHEK2 germline variants identified in familial nonmedullary thyroid cancer lead to impaired protein structure and function.
Pires C; Marques IJ; Valério M; Saramago A; Santo PE; Santos S; Silva M; Moura MM; Matos J; Pereira T; Cabrera R; Lousa D; Leite V; Bandeiras TM; Vicente JB; Cavaco BM
J Biol Chem; 2024 Mar; 300(3):105767. PubMed ID: 38367672
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel germline FOXE1 variant in patients with familial non-medullary thyroid carcinoma (FNMTC).
Pereira JS; da Silva JG; Tomaz RA; Pinto AE; Bugalho MJ; Leite V; Cavaco BM
Endocrine; 2015 May; 49(1):204-14. PubMed ID: 25381600
[TBL] [Abstract][Full Text] [Related]
19. Targeted DNA Sequencing Detects Mutations Related to Susceptibility among Familial Non-medullary Thyroid Cancer.
Yu Y; Dong L; Li D; Chuai S; Wu Z; Zheng X; Cheng Y; Han L; Yu J; Gao M
Sci Rep; 2015 Nov; 5():16129. PubMed ID: 26530882
[TBL] [Abstract][Full Text] [Related]
20. Genetic Mutations and Variants in the Susceptibility of Familial Non-Medullary Thyroid Cancer.
Miasaki FY; Fuziwara CS; Carvalho GA; Kimura ET
Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33218058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]